Research seeks to prevent vision loss in infants with congenital glaucoma

Without treatment, congenital glaucoma can lead to vision loss, often before a baby ever takes his first steps.

Unraveling how this eye disease occurs is the goal of Colleen McDowell, PhD, Research Assistant Professor of Cell Biology and Immunology. A $60,000 grant from the Knights Templar Eye Foundation is funding her research on this condition that affects one in every 10,000 infants.

Unlike most types of glaucoma that develop slowly and occur late in life, congenital glaucoma is present at birth, develops quickly and is much more severe, Dr. McDowell said.

Normally fluid leaves a healthy eye through a tiny drain. The eye then makes more fluid to replace what is lost. But this balance is thrown off in an eye with glaucoma because the fluid does not drain properly.

“With congenital glaucoma, pressure in the eye gets really high, really fast,” Dr. McDowell said. “In small children this ends up killing cells in the back of the eyes that are responsible for vision.”

Her research will focus on pinpointing the cells that are dying first.

“If I can identity those that are dying the fastest, then it’s possible to target and save those cells first,” she said. “That can hopefully lead to therapies that prevent the death of the cells that are responsible for vision loss.”

The symptoms, which might not be apparent at birth, include light sensitivity and excessive tearing caused by malfunctions in the drainage system. Often the child’s eyes are unusually large because of high pressure building up, Dr. McDowell said.

If the disease is diagnosed early, structural damage can be treated with surgery and most children do well. But once vision is lost, it cannot be restored.

Dr. McDowell hopes that her research will lead to therapies that help prevent vision loss in children with the disease.

The Knights Templar Eye Foundation’s pediatric ophthalmology grants support researchers at the beginning of their careers who are committed to the prevention and cure of potentially blinding eye diseases in infants and children.

To date, it has directed more than $23 million to such research efforts.

Recent News

Ashenafi 768x768
  • Our People
|Sep 20, 2023

Dr. Ashenafi Cherkos awarded prestigious AIM-AHEAD Fellowship in Leadership

Dr. Ashenafi Cherkos, assistant professor at The University of North Texas Health Science Center at Fort Worth, has been awarded the prestigious AIM-AHEAD Fellowship in Leadership for the Fall 2023 cohort. Cherkos serves in the School of Public Health’s Department of Population and Community Healt...
  • On Campus
|Sep 20, 2023

Innovate Fort Worth podcast: DJ Perera of New Age Media New Age Learning program

Innovate Fort Worth, the local podcast showcasing local innovation and its dynamic creators, recently featured DJ Perera, a trailblazing artist and educator. Hosted by Cameron Cushman of The University of North Texas Health Science Center at Fort Worth, the podcast episode delves into the intersecti...
Darlene Watkins
  • On Campus
|Sep 20, 2023

HSC student advocates for falls prevention awareness in Tarrant County

Darlene Watkins has dedicated her life to creating healthier and sustainable communities. Her background in interdisciplinary design led her to work with various community organizations from Atlanta to California, but it was her passion for educating aging populations that fueled her desire to wo...
Glenn Forister
  • On Campus
|Sep 19, 2023

HSC’s School of Health Professions to host Health Professions Workforce Symposium

Modern medicine is a team sport, and roughly 60% of that team is composed of practitioners who exist outside of the doctor-nurse paradigm. These vital pillars make up the backbone of the $3 trillion health care sector, and they’re among the fastest-growing professions in the world. From 5 to 8 p....